期刊文献+

贵州省271家医疗机构门诊全身用糖皮质激素的使用现状调查研究 被引量:2

Systemicadministration of glucocorticoids in Guizhou province: a survey among 271 hospital outpatient pharmacies
原文传递
导出
摘要 目的:调查贵州省全身用糖皮质激素(GCs)的使用现状,评价当前GCs相关管理措施的效果。方法:基于贵州省药事管理质量控制中心,采用问卷调查全省各医疗机构GCs的使用情况。采用χ~2检验和方差分析进行单因素分析,Logistic回归和多元线性回归模型分析影响GCs使用的相关因素。结果:全省最终纳入271家已开展诊疗服务的医疗机构。2018年贵州省各医疗机构全身用GCs人均使用量为10.19 mg/人次(按氢化可的松计算),且三级医院的最高(25.69 mg/人次)。共有51家医疗机构(占18.82%)将普通感染退热止痛作为全身用GCs的主要适应证,且这种现象在基层乡镇卫生院尤为突出。目前常用的GCs管理措施在各医疗机构的执行力度不足,且多因素分析结果显示,这些干预措施对于促进GCs的合理使用效果不佳。结论:贵州省GCs不合理使用现象较为突出,因此是未来药事管理质控工作的重点管控品种,特别是要严格把控GCs应用的指征。 OBJECTIVE To investigate the current status of the use of systemic glucocorticoids(GCs)in Guizhou Province and evaluate the effect of current management measures related to GCs.METHODS Based on the Quality Control Center of Guizhou Pharmacy Administration,a questionnaire survey was conducted on the use of GCs in medical institutions throughout the province.Univariate analysis was performed usingχ~2 test and analysis of variance,and logistic regression and multiple linear regression models were used to analyze the factors associated with the use of GCs.RESULTS 271 medical institutions have been included.In 2018,the per capita use of GCs for systemic use in medical institutions in Guizhou Province was 10.19 mg/person(calculated as hydrocortisone),which was the highest in tertiary hospitals(25.69 mg/person).A total of 51 medical institutions(18.82%)considered fever and pain caused by common infections as the main indications for GCs for systemic use,and this phenomenon was particularly prominent in grass-roots township hospitals.At present,the implementation of commonly used GCs management measures in medical institutions is insufficient,and the results of multivariate analysis show that these interventions are not effective in promoting the rational use of GCs.CONCLUSION The status of irrational use of GCs in Guizhou Province is alerting,especially in GHC.It is necessary to restrict the indication for GCs use and improve current management interventions.
作者 张家兴 熊世娟 徐畅 高玲 李莲华 陈琦 谢娟 ZHANG Jia-xing;XIONG Shi-juan;XU Chang;GAO Ling;LI Lian-hua;CHEN Qi;XIE Juan(Department of Pharmacy,Guizhou Provincial People’s Hospital,Guizhou Guiyang 550002,China;Chinese EvidencebasedMedicine Center,Sichuan University,Sichuan Chengdu 610041,China)
出处 《中国医院药学杂志》 CAS 北大核心 2020年第2期219-224,共6页 Chinese Journal of Hospital Pharmacy
关键词 糖皮质激素 药事管理 贵州省 调查研究 glucocorticoid pharmacy administration Guizhou province survey research
  • 相关文献

参考文献10

二级参考文献67

  • 1唐双意,刘滔滔,钟小斌,蒋霞,李丽萍.某“三甲”医院2009年1-6月糖皮质激素应用分析[J].中国药房,2011,22(14):1258-1261. 被引量:11
  • 2吴君华,柳晨,裴元英.布地奈德剂型的研究进展及其临床应用[J].中国临床药学杂志,2007,16(1):59-62. 被引量:34
  • 3郭德云.肾上腺皮质激素诱发或加重结核病68例分析[J].中国防痨杂志,1997,19(8):187-187.
  • 4杨宝峰.药理学[M].7版.北京:人民卫生出版社,2008:350.
  • 5Annane D,Bellissant E,Bollaert PE,et al.Corticosteroids in the treatment of severe sepsis and septic shock in adults:a systematic review[J].JAMA,2009,301(22):2362-2375.
  • 6Marik PE.Mechanisms and clinical consequences of critical illness associated adrenal insufficiency[J].Curt Opin Crit Care,2007,13:363-369.
  • 7Kamiyama K,Matsuda N,Yamamoto S,et al.Modulation of glucocorticoid receptor expression,inflammation,and cell apoptosis in septic guinea pig lungs using methylprednisolone[J].Am J Physiol Lung Cell Mol Physiol,2008,295(6):L998-L1006.
  • 8Cooper MS,Stewart PM.Corticosteroid insufficiency in acutely ill patients[J].N Engl J Med,2003,348:727-734.
  • 9Bernard G.The International Sepsis Forum's controversies insepsis:corticosteroids should not be routinely used to treat septic shock[J].Crit Care 2002,6(5):384-386.
  • 10Annane D,Bellissant E,Bollaert PE,et al.Corticosteroids for treating severe sepsis and septic shock[J].Cochrane Database of Syst Rev,2004,(1):CD002243.

共引文献110

同被引文献14

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部